ATE283068T1 - Biologisch wirksame konjugate mit einem reporterrest und verfahren zu dessen nachweis - Google Patents

Biologisch wirksame konjugate mit einem reporterrest und verfahren zu dessen nachweis

Info

Publication number
ATE283068T1
ATE283068T1 AT99973261T AT99973261T ATE283068T1 AT E283068 T1 ATE283068 T1 AT E283068T1 AT 99973261 T AT99973261 T AT 99973261T AT 99973261 T AT99973261 T AT 99973261T AT E283068 T1 ATE283068 T1 AT E283068T1
Authority
AT
Austria
Prior art keywords
detection
biologically effective
effective conjugates
reporter residue
aim
Prior art date
Application number
AT99973261T
Other languages
English (en)
Inventor
Oddone Schiavon
F Marzolo Via
Paolo Caliceti
Piero Orsolini
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Application granted granted Critical
Publication of ATE283068T1 publication Critical patent/ATE283068T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99973261T 1998-12-08 1999-12-08 Biologisch wirksame konjugate mit einem reporterrest und verfahren zu dessen nachweis ATE283068T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98123307A EP1008355A1 (de) 1998-12-08 1998-12-08 Verfahren zur Identifizierung der Bindungsstellen eines Polymeren an Makromolekülen mit Markierungsbindung von Aminosäuren
PCT/IB1999/001957 WO2000033881A1 (en) 1998-12-08 1999-12-08 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative

Publications (1)

Publication Number Publication Date
ATE283068T1 true ATE283068T1 (de) 2004-12-15

Family

ID=8233105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973261T ATE283068T1 (de) 1998-12-08 1999-12-08 Biologisch wirksame konjugate mit einem reporterrest und verfahren zu dessen nachweis

Country Status (10)

Country Link
US (1) US6790942B1 (de)
EP (2) EP1008355A1 (de)
JP (1) JP2002531529A (de)
AT (1) ATE283068T1 (de)
AU (1) AU757665B2 (de)
CA (1) CA2354868A1 (de)
DE (1) DE69922245T2 (de)
DK (1) DK1137442T3 (de)
ES (1) ES2233107T3 (de)
WO (1) WO2000033881A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100396983B1 (ko) * 2000-07-29 2003-09-02 이강춘 고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
WO2003078461A1 (en) 2002-03-20 2003-09-25 Biopolymed Inc. Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue
ES2323465T3 (es) 2003-05-12 2009-07-16 Affymax, Inc. Peptidos novedosos que se unen al receptor de la eritropoyetina.
ES2395413T3 (es) 2003-05-12 2013-02-12 Affymax, Inc. Péptidos que se unen al receptor de eritropoyetina
MXPA05012314A (es) 2003-05-12 2006-04-18 Affymax Inc Radical separador para peptido modificado con polietilenglicol.
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
EP2118127A4 (de) 2007-01-31 2010-12-01 Affymax Inc Linker auf stickstoffbasis zur bindung modifizierender gruppen an polypeptide und andere makromoleküle
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US9879059B2 (en) * 2013-04-26 2018-01-30 Agency For Science, Technology And Research Tailoring multivalent interactions of biopolymers with a polyproline scaffold

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219454B (it) * 1988-02-17 1990-05-18 Serono Cesare Ist Ricerca Metodo di rottura alla metionina di polipeptidi contenenti pontidisolfuro
DK0437563T3 (da) * 1989-08-07 1995-05-29 Debio Rech Pharma Sa Bioligiske aktive lægemiddelpolymerderivater
US5286637A (en) * 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
WO1992020362A1 (en) * 1991-05-14 1992-11-26 Shashoua Victor E Nerve growth peptides and uses therefor
DK0536671T3 (da) * 1991-10-07 1996-08-12 Hoechst Ag Carboxylsyreester-beskyttelsesgrupper, en fremgangsmåde til deres fremstilling, kobling til funktionelle grupper samt deres anvendelser

Also Published As

Publication number Publication date
EP1137442B1 (de) 2004-11-24
ES2233107T3 (es) 2005-06-01
AU1402800A (en) 2000-06-26
DE69922245D1 (de) 2004-12-30
CA2354868A1 (en) 2000-06-15
AU757665B2 (en) 2003-02-27
US6790942B1 (en) 2004-09-14
WO2000033881A1 (en) 2000-06-15
DK1137442T3 (da) 2005-03-14
DE69922245T2 (de) 2005-11-24
EP1137442A1 (de) 2001-10-04
JP2002531529A (ja) 2002-09-24
EP1008355A1 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
DK1053355T3 (da) PNA- og DNA-konjugater og metoder til fremstilling heraf
ATE222254T1 (de) Verwendung von einem metalloporphyrinkonjugat für den nachweis biologischer verbindungen
ATE191515T1 (de) Verfahren und zusammensetzungen zum analysieren von nukleinsäuremolekulen mittels bemessungstechniken
ATE360033T1 (de) Ortsspezifische proteinmodifizierung durch mutagenese
IL169437A (en) Method for assessing interactions and a method for identifying target and non-target biomolecules in a mixture of biomolecules by contacting a capture molecule with a sample
ATE246361T1 (de) Verfahren zur bestimmung von ige
ATE426018T1 (de) Pca3, pca3-gene und verfahren zu ihrer verwendung
ATE204290T1 (de) Zusammensetzungen und verfahren zur immobilisierung von nukleinsäure auf festträgern
ATE129347T1 (de) Biologisch aktive reagenzien aus carboxylgruppenhaltigen polymerisaten, analytisches element und verfahren zur verwendung.
ATE283068T1 (de) Biologisch wirksame konjugate mit einem reporterrest und verfahren zu dessen nachweis
ATE250143T1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
DE68929334D1 (de) Verfahren zumm Assay von Endotoxin-Konzentration
ATE319996T1 (de) Verfahren zum auffinden eines heilmittels für krebs mit hilfe von interaktionsdomänen von p53 und mortalin
ATE233405T1 (de) Verfahren zur detektierung eines biologischen materials, eingangphase, detektionsphase und diese enthaltende reagenz
DE69902796T2 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
ATE284034T1 (de) Verfahren zum nachweis von protein s
ATE319735T1 (de) Aufreinigung von substanzen aus einer biologischen probe
AU2003302133A8 (en) Uses of ble proteins and antibiotics from the bleomycin family
ATE481641T1 (de) Verfahren zur fixierung eines proteins auf einem pyrrolpolymerisat, und dessen verwendung zur herstellung eines sensors
WO1995003066A1 (en) Selective modification of the carboxy therminus of a protein
DE59913678D1 (de) Verfahren zum Nachweis von Änderungen in Biopolymeren
ATE466953T1 (de) Verfahren zur identifizierung aktivierter polymer-komplexe zur sekundären stellen-spezifischen modifikation von protein ziel-gruppen.
WO2003091404A3 (en) Formation and use of site specific nucleic acid coupled binding polypeptides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137442

Country of ref document: EP

REN Ceased due to non-payment of the annual fee